Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-22-050762
Filing Date
2022-08-24
Accepted
2022-08-24 15:37:39
Documents
15
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2021a1_viveon.htm   iXBRL 10-K/A 44018
2 CERTIFICATION f10k2021a1ex31-1_viveon.htm EX-31.1 11879
3 CERTIFICATION f10k2021a1ex31-2_viveon.htm EX-31.2 11676
  Complete submission text file 0001213900-22-050762.txt   298091

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vhaq-20211231.xsd EX-101.SCH 3269
5 XBRL DEFINITION FILE vhaq-20211231_def.xml EX-101.DEF 17324
6 XBRL LABEL FILE vhaq-20211231_lab.xml EX-101.LAB 35705
7 XBRL PRESENTATION FILE vhaq-20211231_pre.xml EX-101.PRE 18424
9 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021a1_viveon_htm.xml XML 6295
Mailing Address C/O GIBSON, DEAL, AND FLETCHER, P. C. 3953 NORCROSS GA 30092
Business Address C/O GIBSON, DEAL, AND FLETCHER, P. C. 3953 NORCROSS GA 30092 4045797978
Viveon Health Acquisition Corp. (Filer) CIK: 0001823857 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39827 | Film No.: 221191433
SIC: 2834 Pharmaceutical Preparations